The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab.
Zhou, Li
The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab. [electronic resource] - Journal of clinical laboratory analysis Jun 2019 - e22862 p. digital
Publication Type: Clinical Trial; Journal Article
1098-2825
10.1002/jcla.22862 doi
Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Arthritis, Rheumatoid--blood
Biomarkers--blood
Female
Hemoglobins--analysis
Humans
Lymphocyte Count
Male
Middle Aged
Neutrophils--drug effects
Platelet Count
Prospective Studies
Treatment Outcome
The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab. [electronic resource] - Journal of clinical laboratory analysis Jun 2019 - e22862 p. digital
Publication Type: Clinical Trial; Journal Article
1098-2825
10.1002/jcla.22862 doi
Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Arthritis, Rheumatoid--blood
Biomarkers--blood
Female
Hemoglobins--analysis
Humans
Lymphocyte Count
Male
Middle Aged
Neutrophils--drug effects
Platelet Count
Prospective Studies
Treatment Outcome